BioSpace News Archive

Roquette, a leading provider of pharmaceutical excipients and global leader in plant-based ingredients, is pleased to announce a strategic investment with Beren Therapeutics P.B.C., and the launch of an innovation agreement to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.

Eisai announced the presentation of research across various types of cancer from its oncology portfolio and pipeline during the 2023 American Society of Clinical Oncology Annual Meeting, which is taking place virtually and in-person in Chicago, Illinois from June 2 to 6.

Exo Therapeutics, Inc. today announced its lead program directed against TBK1, and the appointment of Alexandra Joseph, PhD, as Executive Vice President of Biology.

Moximed announced two new peer-reviewed publications reported additional supporting data for the MISHA™ Knee System, an implantable shock absorber for patients with osteoarthritis who are not ready for a knee replacement.

Horizon Therapeutics plc (Nasdaq: HZNP) today announced plans for the first presentation of data from a Phase 2 study of dazodalibep, the company’s investigational therapy for Sjögren’s syndrome, during the 2023 EULAR European Congress of Rheumatology, May 31 - June 3, 2023, in Milan.

Company also adds Dr. Parameswaran Hari as Chief Development Officer and appoints Dr. Matthew Norkunas to Board of Directors.

The bioanalytical CRO companies formerly known as Pyxant Labs Inc. and ImaBiotech Group, which joined forces in 2021, are pleased to announce their new identity as Aliri.

Galecto, Inc. (NASDAQ: GLTO) today announced the last dosing of the last patient in the GALACTIC-1 Phase 2b trial of its most advanced product candidate, GB0139, for the treatment of idiopathic pulmonary fibrosis (IPF).

Surgalign Holdings, Inc. announced today that it will be exhibiting at ISASS 2023 – the 23rd Annual Conference – sponsored by the International Society for Spine Surgery.

Predictive Oncology, Inc. (NASDAQ: POAI) announced today that the company’s Chief Business Officer, Pamela Bush, Ph.D., MBA, will present at the upcoming 2023 BIO International Convention , in Boston, Massachusetts, on June 5, 2023, at 2:45 p.m. ET, Presentation Room 103.